Stay updated on Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial
Sign up to get notified when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.

Latest updates to the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; this appears to be a minor site revision with no visible changes to study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedThe page now lists Revision: v3.3.1, replacing the previous Revision: v3.2.0. This appears to be a minor maintenance update with no impact on the clinical trial details or data.SummaryDifference0.0%

- Check29 days agoChange DetectedRemoved the government funding/operating status notice from the page; the core trial information such as design, eligibility criteria, and endpoints remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check43 days agoChange DetectedMinor formatting and wording changes were made to the Study Details page. No core data such as eligibility criteria, interventions, outcomes, enrollment, or locations appear to have changed.SummaryDifference0.4%

- Check71 days agoChange DetectedPage now includes an official operating-status notice and updates version to v3.2.0, replacing v3.1.0.SummaryDifference3%

- Check79 days agoChange DetectedRemoved several drug safety and disease info topics and updated the version to v3.1.0, signaling content reduction with a minor version upgrade.SummaryDifference0.8%

Stay in the know with updates to Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.